drugset / Trial / NCT01728454
Safety and Efficacy of Telapristone Acetate (Proellex®) in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary purpose of this study is to determine the safety and efficacy of two oral doses of telapristone acetate administered to premenopausal women with pelvic pain associated with endometriosis confirmed within the last seven years and using prescription analgesics for symptomatic pain.
Timeline
- Start
- 2013-05-02
- Primary completion
- 2017-03-15
- Completion
- 2017-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telapristone Acetate | Other / unclassified | 6 mg | Oral |
| Subject | Telapristone Acetate | Other / unclassified | 12 mg | Oral |